• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用钬:钇铝石榴石激光进行心肌血运重建。

Transmyocardial revascularization utilizing a holmium:YAG laser.

作者信息

Allen K B, Dowling R D, Heimansohn D A, Reitsma E, Didelot L, Shaar C J

机构信息

Department of Cardiovascular/Thoracic Surgery, St. Vincent Hospital and Health Care Center Indianapolis, IN, USA.

出版信息

Eur J Cardiothorac Surg. 1998 Oct;14 Suppl 1:S100-4. doi: 10.1016/s1010-7940(98)00114-6.

DOI:10.1016/s1010-7940(98)00114-6
PMID:9814802
Abstract

OBJECTIVE

To evaluate the efficacy of transmyocardial revascularization performed on patients with refractory class IV or unstable angina with a holmium:yttrium-aluminum-garnet laser.

METHODS

Transmyocardial revascularization with a holmium:yttrium-aluminum-garnet laser was performed in 42 patients with refractory angina who were not candidates for percutaneous transluminal coronary angioplasty or coronary artery bypass grafting. Patients had either Canadian Heart Association class IV angina (n = 23) or unstable angina (n = 19) and were unable to be weaned from intravenous nitroglycerin. Preoperative thallium studies identified the extent and location of reversible ischemia. Operative exposure was via a limited left anterior thoracotomy. An average of 45+/-11 laser channels were created with a mean operative time of 106+/-38 min.

RESULTS

Perioperative mortality was 12% (5/42) with no late deaths. Complications included ventricular 7.1% (3/42) and atrial 4.7% (2/42) arrhythmias, reoperation for chest-wall hemorrhage 2% (1/42), and respiratory failure requiring reintubation 2% (1/42). Intra-aortic balloon pump placement was required in 12% (5/42). The mean postoperative length of stay was 5.5+/-4.9 (1-25) days. Mean follow-up on 100% of patients is 5.4+/-3.0 (1-12) months. At 3 (n = 33) and 6 (n = 21) months follow-up the mean angina class was 1.5+/-0.1 (P < 0.002) and 1.1+/-0.1 (P < 0.001), respectively.

CONCLUSIONS

Transmyocardial revascularization utilizing a holmium:yttrium-aluminum-garnet laser resulted in a significant reduction in angina class and was beneficial in patients with refractory angina untreatable by conventional methods.

摘要

目的

评估用钬:钇铝石榴石激光对IV级难治性或不稳定型心绞痛患者进行心肌血运重建的疗效。

方法

对42例难治性心绞痛患者进行钬:钇铝石榴石激光心肌血运重建,这些患者不适合经皮腔内冠状动脉成形术或冠状动脉旁路移植术。患者为加拿大心脏协会IV级心绞痛(n = 23)或不稳定型心绞痛(n = 19),且无法停用静脉硝酸甘油。术前铊研究确定了可逆性缺血的范围和位置。手术暴露通过有限的左前开胸术进行。平均创建了45±11个激光通道,平均手术时间为106±38分钟。

结果

围手术期死亡率为12%(5/42),无晚期死亡。并发症包括7.1%(3/42)的室性和4.7%(2/42)的房性心律失常,因胸壁出血再次手术2%(1/42),以及需要重新插管的呼吸衰竭2%(1/42)。12%(5/42)的患者需要放置主动脉内球囊泵。术后平均住院时间为5.5±4.9(1 - 25)天。对100%的患者平均随访5.4±3.0(1 - 12)个月。在3个月(n = 33)和6个月(n = 21)随访时,平均心绞痛分级分别为1.5±0.1(P < 0.002)和1.1±0.1(P < 0.001)。

结论

使用钬:钇铝石榴石激光进行心肌血运重建可使心绞痛分级显著降低,对常规方法无法治疗的难治性心绞痛患者有益。

相似文献

1
Transmyocardial revascularization utilizing a holmium:YAG laser.利用钬:钇铝石榴石激光进行心肌血运重建。
Eur J Cardiothorac Surg. 1998 Oct;14 Suppl 1:S100-4. doi: 10.1016/s1010-7940(98)00114-6.
2
Transmyocardial holmium laser revascularization: feasibility of a thoracoscopic approach.经心肌钬激光血运重建术:胸腔镜入路的可行性
Eur J Cardiothorac Surg. 1998 Oct;14 Suppl 1:S105-10. doi: 10.1016/s1010-7940(98)00115-8.
3
[Transmyocardial revascularization with a holmium laser: preliminary results].钬激光心肌血运重建术:初步结果
G Ital Cardiol. 1997 Oct;27(10):1011-8.
4
Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease.终末期冠状动脉疾病患者的导管介导经皮心肌激光血运重建术
J Am Coll Cardiol. 1999 Nov 15;34(6):1663-70. doi: 10.1016/s0735-1097(99)00419-2.
5
Percutaneous transluminal myocardial revascularization with a holmium laser system: procedural results and early clinical outcome.钬激光系统经皮腔内心肌血运重建术:手术结果及早期临床结局
Catheter Cardiovasc Interv. 1999 Jul;47(3):287-91. doi: 10.1002/(sici)1522-726x(199907)47:3<287::aid-ccd5>3.0.co;2-o.
6
Mid-term results after thoracoscopic transmyocardial laser revascularization.
Ann Thorac Surg. 2005 Aug;80(2):553-8. doi: 10.1016/j.athoracsur.2005.02.060.
7
Transmyocardial revascularization in patients with refractory, unstable angina.
Circulation. 1998 Nov 10;98(19 Suppl):II73-5; discussion II75-6.
8
Quality of life and survival after transmyocardial laser revascularization with the holmium:YAG laser.钬激光心肌打孔血运重建术后的生活质量与生存率
Ann Thorac Surg. 2003 Jun;75(6):1842-7; discussion 1847-8. doi: 10.1016/s0003-4975(03)00178-4.
9
Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass.经心肌激光血运重建术与冠状动脉搭桥术联合应用的中期结果
Ann Thorac Surg. 2003 Oct;76(4):1163-6. doi: 10.1016/s0003-4975(03)00829-4.
10
Percutaneous transmyocardial revascularization with holmium laser in patients with refractory angina: a pilot feasibility study.钬激光经皮心肌血运重建术治疗顽固性心绞痛患者:一项初步可行性研究。
G Ital Cardiol. 1999 Sep;29(9):1020-6.

引用本文的文献

1
Transmyocardial revascularization (TMR): current status and future directions.经心肌血运重建术(TMR):现状与未来方向。
Indian J Thorac Cardiovasc Surg. 2018 Dec;34(Suppl 3):330-339. doi: 10.1007/s12055-018-0702-7. Epub 2018 Oct 8.
2
Refractory Angina: the Current State of Mechanical Therapies.难治性心绞痛:机械治疗的现状。
Curr Cardiol Rep. 2019 Apr 22;21(6):46. doi: 10.1007/s11886-019-1134-8.
3
Clinical outcomes meta-analysis: measuring subendocardial perfusion and efficacy of transmyocardial laser revascularization with nuclear imaging.
临床结果荟萃分析:利用核成像测量心肌内膜下灌注及心肌激光血运重建术的疗效。
J Cardiothorac Surg. 2017 May 19;12(1):37. doi: 10.1186/s13019-017-0602-8.
4
[Long-term results of percutaneous transmyocardial laser revascularization therapy at the University of Vienna Medical Center].
Wien Klin Wochenschr. 2004 Apr 30;116(7-8):252-9. doi: 10.1007/BF03041056.